Transjugular intrahepatic portal‐systemic shunt in the treatment of refractory ascites: Effect on clinical, renal, humoral, and hemodynamic parameters
Jorge Quiroga, Bruno Sangro, Marina Núñez, Ignacio Bilbao, Jesús Longo, Luis García‐Villarreal, José M. Zozaya, Maite Betés, José I. Herrero, Jesús Prieto – 1 April 1995 – Seventeen cirrhotics with refractory ascites were treated with transjugular intrahepatic portosystemic shunt (TIPS) and followed for 15.5 ± 3.4 months. Five patients died, four within 3 months after TIPS (hepatocellular failure) and one after 22 months (cholangiocarcinoma). Six patients received transplants 1 to 10 months after the procedure. Actuarial survival at 6, 12, and 24 months was 75%, 75%, and 63%, respectively.